Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record now presents the KEYNOTE-811 study details, including its treatment comparison, eligibility criteria, outcome measures, and completed status. It also includes study locations, publications, record dates, and supporting documents.
    Difference
    100%
    Check dated 2026-11-11T17:09:34.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T15:31:07.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-21T14:51:23.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision marker changed from v3.7.1 to v3.7.2; the study page remains an access-denied error.
    Difference
    0.2%
    Check dated 2026-10-14T15:21:09.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer’s displayed revision changed from v3.7.0 to v3.7.1, while the page continues to show a 403 error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-07T14:52:51.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a simple header and a Home link. This replaces the previous study record content for the NCT03615326 entry.
    Difference
    20%
    Check dated 2026-09-23T20:12:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.